Alcoholic liver disease: Treatment

被引:55
作者
Suk, Ki Tae [1 ]
Kim, Moon Young [2 ]
Baik, Soon Koo [2 ]
机构
[1] Hallym Univ, Coll Med, Dept Internal Med, Chunchon 200704, South Korea
[2] Yonsei Univ, Wonju Severance Christian Hosp, Wonju Coll Med, Dept Internal Med, Wonju 220701, South Korea
关键词
Liver disease; Alcoholic; Treatment; SHORT-TERM SURVIVAL; PROTEIN-CALORIE MALNUTRITION; RANDOMIZED CONTROLLED-TRIAL; DE-NOVO MALIGNANCIES; AND/OR HEPATITIS-B; DOUBLE-BLIND; FATTY LIVER; NUTRITIONAL SUPPORT; ENTERAL NUTRITION; RETROSPECTIVE ANALYSIS;
D O I
10.3748/wjg.v20.i36.12934
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The excess consumption of alcohol is associated with alcoholic liver diseases (ALD). ALD is a major healthcare problem, personal and social burden, and significant reason for economic loss worldwide. The ALD spectrum includes alcoholic fatty liver, alcoholic hepatitis, cirrhosis, and the development of hepatocellular carcinoma. The diagnosis of ALD is based on a combination of clinical features, including a history of significant alcohol intake, evidence of liver disease, and laboratory findings. Abstinence is the most important treatment for ALD and the treatment plan varies according to the stage of the disease. Various treatments including abstinence, nutritional therapy, pharmacological therapy, psychotherapy, and surgery are currently available. For severe alcoholic hepatitis, corticosteroid or pentoxifylline are recommended based on the guidelines. In addition, new therapeutic targets are being under investigation. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:12934 / 12944
页数:11
相关论文
共 129 条
  • [91] Are preoperative patterns of alcohol consumption predictive of relapse after liver transplantation for alcoholic liver disease?
    Perney, P
    Bismuth, M
    Sigaud, H
    Picot, MC
    Jacquet, E
    Puche, P
    Jaber, S
    Rigole, H
    Navarro, F
    Eledjam, JJ
    Blanc, F
    Larrey, D
    Pageaux, GP
    [J]. TRANSPLANT INTERNATIONAL, 2005, 18 (11) : 1292 - 1297
  • [92] Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence
    Pessione, F
    Ramond, MJ
    Peters, L
    Pham, BN
    Batel, P
    Rueff, B
    Valla, DC
    [J]. LIVER INTERNATIONAL, 2003, 23 (01) : 45 - 53
  • [93] Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease
    Pfitzmann, Robert
    Schwenzer, Jeannette
    Rayes, Nada
    Seehofer, Daniel
    Neuhaus, Ruth
    Nuessler, Natascha C.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (02) : 197 - 205
  • [94] ESPEN guidelines on enteral nutrition:: Liver disease
    Plauth, M.
    Cabre, E.
    Riggio, O.
    Assis-Camilo, M.
    Pirlich, M.
    Kondrup, J.
    Ferenci, P.
    Holm, E.
    vom Dahl, S.
    Mueller, M. J.
    Nolte, W.
    [J]. CLINICAL NUTRITION, 2006, 25 (02) : 285 - 294
  • [95] ESPEN Guidelines on Parenteral Nutrition: Hepatology
    Plauth, Mathias
    Cabre, Eduard
    Campillo, Bernard
    Kondrup, Jens
    Marchesini, Giulio
    Schuetz, Tatjana
    Shenkin, Alan
    Wendon, Julia
    [J]. CLINICAL NUTRITION, 2009, 28 (04) : 436 - 444
  • [96] Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice
    Pritchard, Michele T.
    McMullen, Megan R.
    Stavitsky, Abram B.
    Cohen, Jessica I.
    Lin, Feng
    Medof, M. Edward
    Nagy, Laura E.
    [J]. GASTROENTEROLOGY, 2007, 132 (03) : 1117 - 1126
  • [97] Systematic review: glucocorticosteroids for alcoholic hepatitis - a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials
    Rambaldi, A.
    Saconato, H. H.
    Christensen, E.
    Thorlund, K.
    Wetterslev, J.
    Gluud, C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (12) : 1167 - 1178
  • [98] Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis
    Rambaldi, A
    Gluud, C
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (02):
  • [99] Milk thistle for alcoholic and/or hepatitis B or C liver diseases - A systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials
    Rambaldi, A
    Jacobs, BP
    Iaquinto, G
    Gluud, C
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11) : 2583 - 2591
  • [100] Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases - art. no. CD003620.pub2
    Rambaldi, A
    Jacobs, BP
    Iaquinto, G
    Gluud, C
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (02):